ArticleCancer immunology, immunotherapy : CII2019

Pre-existing autoimmune disease and the risk of immune-related adverse events among patients receiving checkpoint inhibitors for cancer.

Kenneth L Kehl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.